Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    72
    CASES:
    24
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    9
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR721
$195.00
Add To Collect

Description: Uterus cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores

Details: Uterine carcinoma with normal tissue microarray, containing 17 cases of endometrioid adenocarcinoma, 1 clear cell carcinoma, 3 each of adjacent normal tissue and normal tissue, triplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • NAT(*)
  • Normal(*)
  • Malignant(I)
  • Malignant(IB)
  • Malignant(IC)
  • Malignant(II)
  • Malignant(IIIC)
  • _ma
TISSUE ARRAYS
FUR721
1
2
3
4
5
6
7
8
9
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
H
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
_ma
FUR721
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 44 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 I Malignant
A2
2 44 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 I Malignant
A3
3 44 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 I Malignant
A4
4 62 F Uterus Endometrioid adenocarcinoma 1 T1b1N1M0 IIIC Malignant
A5
5 62 F Uterus Endometrioid adenocarcinoma 1 T1b1N1M0 IIIC Malignant
A6
6 62 F Uterus Endometrioid adenocarcinoma 1 T1b1N1M0 IIIC Malignant
A7
7 61 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A8
8 61 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A9
9 61 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
B1
10 42 F Uterus Endometrioid adenocarcinoma (sparse) 1 T1N0M0 I Malignant
B2
11 42 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B3
12 42 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B4
13 39 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B5
14 39 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B6
15 39 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B7
16 50 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B8
17 50 F Uterus Endometrioid adenocarcinoma with cataplasia and necrotic tissue 1 T1N0M0 I Malignant
B9
18 50 F Uterus Endometrioid adenocarcinoma (sparse) with squamous metaplasia 1 T1N0M0 I Malignant
C1
19 47 F Uterus Endometrioid adenocarcinoma (smooth muscle) * T1b1N1M0 IIIC Malignant
C2
20 47 F Uterus Endometrioid adenocarcinoma (smooth muscle) * T1b1N1M0 IIIC Malignant
C3
21 47 F Uterus Endometrioid adenocarcinoma (smooth muscle) * T1b1N1M0 IIIC Malignant
C4
22 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C5
23 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C6
24 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C7
25 48 F Uterus Endometrioid adenocarcinoma 2--3 T1N0M0 I Malignant
C8
26 48 F Uterus Endometrioid adenocarcinoma 2--3 T1N0M0 I Malignant
C9
27 48 F Uterus Endometrioid adenocarcinoma 2--3 T1N0M0 I Malignant
D1
28 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D2
29 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D3
30 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D4
31 33 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D5
32 33 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D6
33 33 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D7
34 51 F Uterus Endometrioid adenocarcinoma (sparse) 3 T1cN0M0 IC Malignant
D8
35 51 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
D9
36 51 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
E1
37 52 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E2
38 52 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E3
39 52 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E4
40 55 F Uterus Endometrioid adenocarcinoma 2--3 T1N0M0 I Malignant
E5
41 55 F Uterus Endometrioid adenocarcinoma 2--3 T1N0M0 I Malignant
E6
42 55 F Uterus Endometrioid adenocarcinoma 2--3 T1N0M0 I Malignant
E7
43 45 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T1N0M0 I Malignant
E8
44 45 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T1N0M0 I Malignant
E9
45 45 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
F1
46 48 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant
F2
47 48 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant
F3
48 48 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant
F4
49 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F5
50 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F6
51 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F7
52 63 F Uterus Clear cell carcinoma * T3cN1M0 IIIC Malignant
F8
53 63 F Uterus Clear cell carcinoma * T3cN1M0 IIIC Malignant
F9
54 63 F Uterus Clear cell carcinoma with necrosis * T3cN1M0 IIIC Malignant
G1
55 50 F Uterus Adjacent normal endometrial tissue * * * NAT
G2
56 50 F Uterus Adjacent normal endometrial tissue * * * NAT
G3
57 50 F Uterus Adjacent normal endometrial tissue * * * NAT
G4
58 56 F Uterus Adjacent normal endometrial tissue * * * NAT
G5
59 56 F Uterus Adjacent normal endometrial tissue * * * NAT
G6
60 56 F Uterus Adjacent normal endometrial tissue * * * NAT
G7
61 44 F Uterus Adjacent normal endometrial tissue * * * NAT
G8
62 44 F Uterus Adjacent normal endometrial tissue * * * NAT
G9
63 44 F Uterus Adjacent normal endometrial tissue * * * NAT
H1
64 35 F Uterus Normal endometrial tissue * * * Normal
H2
65 35 F Uterus Normal endometrial tissue * * * Normal
H3
66 35 F Uterus Normal endometrial tissue * * * Normal
H4
67 40 F Uterus Normal endometrial tissue (smooth muscle) * * * Normal
H5
68 40 F Uterus Normal endometrial tissue * * * Normal
H6
69 40 F Uterus Normal endometrial tissue * * * Normal
H7
70 21 F Uterus Normal endometrial tissue * * * Normal
H8
71 21 F Uterus Normal endometrial tissue * * * Normal
H9
72 21 F Uterus Normal endometrial tissue * * * Normal
_malignant_melanoma_
Find overlapping cases with this tissue array:
  • FUR721
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:04
    Download
0.900609s